title: Antimalarial activities and therapeutic properties of febrifugine analogs.
abstract: Febrifugine is the active principal isolated 50 years ago from the Chinese herb chang shan (Dichroa febrifuga Lour), which has been used as an antimalarial in Chinese traditional medicine for more than 2,000 years. However, intensive study of the properties of febrifugine has been hindered for decades due to its side effects. We report new findings on the effects of febrifugine analogs compared with those of febrifugine extracted from the dry roots of D. febrifuga. The properties of the extracted febrifugine were comparable to those obtained from the standard febrifugine provided by our collaborators. A febrifugine structure-based computer search of the Walter Reed Chemical Information System identified 10 analogs that inhibited parasite growth in vitro, with 50% inhibitory concentrations ranging from 0.141 to 290 ng/ml. The host macrophages (J744 cells) were 50 to 100 times less sensitive to the febrifugine analogs than the parasites. Neuronal (NG108) cells were even more insensitive to these drugs (selectivity indices, >1,000), indicating that a feasible therapeutic index for humans could be established. The analogs, particularly halofuginone, notably reduced parasitemias to undetectable levels and displayed curative effects in Plasmodium berghei-infected mice. Recrudescence of the parasites after treatment with the febrifugine analogs was the key factor that caused the death of most of the mice in groups receiving an effective dose. Subcutaneous treatments with the analogs did not cause irritation of the gastrointestinal tract when the animals were treated with doses within the antimalarial dose range. In summary, these analogs appear to be promising lead antimalarial compounds that require intensive study for optimization for further down-selection and development.
authors.affiliation: Department of Parasitology, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA. suping.jiang@na.amedd.army.mil
authors.forename: Suping
authors.initials: S
authors.lastname: Jiang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zeng
authors.forename: Montip
authors.initials: M
authors.lastname: Gettayacamin
authors.forename: Anchalee
authors.initials: A
authors.lastname: Tungtaeng
authors.forename: Srisombat
authors.initials: S
authors.lastname: Wannaying
authors.forename: Apassorn
authors.initials: A
authors.lastname: Lim
authors.forename: Pranee
authors.initials: P
authors.lastname: Hansukjariya
authors.forename: Christopher O
authors.initials: CO
authors.lastname: Okunji
authors.forename: Shuren
authors.initials: S
authors.lastname: Zhu
authors.forename: Daohe
authors.initials: D
authors.lastname: Fang
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D002460:Cell Line; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D008813:Mice, Inbred ICR; D010880:Piperidines; D011799:Quinazolines / Q000494:pharmacology*
chemical_list: D000962:Antimalarials; D010880:Piperidines; D011799:Quinazolines; C001207:febrifugine
references.citation: Antimicrob Agents Chemother. 1979 Dec;16(6):710-8
references.pmid: 394674
references.citation: Biochem Pharmacol. 1999 Nov 15;58(10):1593-601
references.pmid: 10535750
references.citation: J Med Chem. 1970 Sep;13(5):867-70
references.pmid: 5458373
references.citation: J Parasitol. 1983 Jun;69(3):577-83
references.pmid: 6355423
references.citation: Biochem Pharmacol. 1996 Oct 11;52(7):1057-63
references.pmid: 8831725
references.citation: Gen Pharmacol. 1998 Apr;30(4):445-50
references.pmid: 9522159
references.citation: J Am Chem Soc. 1949 Mar;71(3):1048-54
references.pmid: 18124517
references.citation: J Am Chem Soc. 1947 Jul;69(7):1837
references.pmid: 20251439
references.citation: J Med Chem. 2002 Jun 6;45(12):2563-70
references.pmid: 12036365
references.citation: Nature. 1948 Mar 13;161(4089):400
references.pmid: 18916817
references.citation: Science. 1999 Sep 3;285(5433):1502-3
references.pmid: 10498534
references.citation: J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12
references.pmid: 2359136
references.citation: J Am Chem Soc. 1948 Jun;70(6):2091-3
references.pmid: 18863804
references.citation: Science. 1976 Aug 20;193(4254):673-5
references.pmid: 781840
references.citation: Adv Pharmacol Chemother. 1973;11:221-93
references.pmid: 4591806
references.citation: Antimicrob Agents Chemother. 2001 Sep;45(9):2577-84
references.pmid: 11502532
references.citation: J Hepatol. 1997 Aug;27(2):391-8
references.pmid: 9288615
references.citation: Heart Vessels. 1998;13(1):18-23
references.pmid: 9923561
references.citation: Pharmacol Ther. 2001 Feb;89(2):207-19
references.pmid: 11316521
references.citation: Science. 1946 Jan 11;103(2663):59
references.pmid: 17835430
references.citation: Neoplasia. 1999 Oct;1(4):321-9
references.pmid: 10935487
references.citation: Connect Tissue Res. 1996;34(2):97-103
references.pmid: 8909874
references.citation: J Med Chem. 2003 Sep 25;46(20):4351-9
references.pmid: 13678413
references.citation: J Med Chem. 1999 Aug 12;42(16):3163-6
references.pmid: 10447961
references.citation: J Nat Prod. 1998 Jun 26;61(6):729-33
references.pmid: 9644055
references.citation: Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1082-6
references.pmid: 8887611